Therefore , our objective was to determine , in virologically suppressed HIV-@-infected individuals , the presence of RAMs to rilpivirine , etravirine and the combination of tenofovir/emtricitabine/rilpivirine in HIV-@ DNA from individuals previously exposed to efavirenz and/or nevirapine .